price
LR
NASDAQ · LRMR
Larimar Therapeutics, Inc.
Healthcare · Biotechnology
$3.85
Down-$0.02 (-0.52%)
Updated Sep 11, 2026, 5:55 AM
SID Score
4.4/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 343.65M
- P/E ratio
- -2.58
- Dividend yield
- 0.00%
- 52-week range
- $2.92 – $6.00
- Volume
- 871.39K
- Avg. volume
- 2.64M
Price performance
LRMR price history
1M range · 20 trading sessions · Daily adjusted prices
LRMR closed at $3.85 after 20 trading sessions, down 9.84% for the selected period.
- Last close
- $3.85
- Period change
- -9.84%
- Period low
- $3.82
- Period high
- $4.36
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 10, 2026 | $3.82 | $3.86 | $3.74 | $3.85 | 871.39K |
| Sep 9, 2026 | $4.03 | $4.17 | $3.83 | $3.87 | 978.8K |
| Sep 8, 2026 | $3.76 | $4.08 | $3.72 | $4.075 | 1.04M |
| Sep 4, 2026 | $3.82 | $3.85 | $3.79 | $3.83 | 391.99K |
| Sep 3, 2026 | $3.90 | $3.90 | $3.7741 | $3.83 | 684.26K |
| Sep 2, 2026 | $3.96 | $4.075 | $3.8218 | $3.87 | 515.56K |
| Sep 1, 2026 | $3.78 | $3.95 | $3.77 | $3.94 | 755.35K |
| Aug 31, 2026 | $3.98 | $4.00 | $3.81 | $3.82 | 1.07M |
| Aug 28, 2026 | $4.03 | $4.08 | $3.98 | $4.01 | 641.51K |
| Aug 27, 2026 | $4.16 | $4.16 | $4.02 | $4.05 | 673.59K |
| Aug 26, 2026 | $4.14 | $4.18 | $4.02 | $4.17 | 702.14K |
| Aug 25, 2026 | $4.08 | $4.235 | $4.08 | $4.16 | 1.08M |
| Aug 24, 2026 | $4.23 | $4.23 | $3.93 | $4.05 | 945.55K |
| Aug 21, 2026 | $4.20 | $4.21 | $4.085 | $4.18 | 699.42K |
| Aug 20, 2026 | $4.21 | $4.21 | $3.975 | $4.16 | 1.16M |
| Aug 19, 2026 | $4.19 | $4.34 | $4.17 | $4.25 | 1.23M |
| Aug 18, 2026 | $4.31 | $4.35 | $4.05 | $4.06 | 869.63K |
| Aug 17, 2026 | $4.33 | $4.4199 | $4.30 | $4.32 | 882.8K |
| Aug 14, 2026 | $4.26 | $4.39 | $4.17 | $4.36 | 1.18M |
| Aug 13, 2026 | $4.38 | $4.465 | $4.23 | $4.27 | 1.5M |
Latest LRMR news
The latest Smart Investors Daily articles mentioning LRMR.
Stock researchMarket Activity · Institutional Ownership
Loading stock research…